Literature DB >> 25906120

CD71 in Gestational Pathology: A Versatile Immunohistochemical Marker With New Possible Applications.

Claudio Luchini1, Pietro Parcesepe, Alessia Nottegar, Claudia Parolini, Andrea Mafficini, Andrea Remo, Marco Chilosi, Erminia Manfrin.   

Abstract

Transferrin receptor/CD71 is a membrane protein expressed on nucleated red blood cells (NRBCs) and trophoblasts. Here, we propose the first study to evaluate the usefulness of CD71 immunolabeling in the main fields of gestational pathology. To this aim, formalin-fixed, paraffin-embedded samples of 45 orthotopic (23 spontaneous abortive and 22 molar pregnancies) and 11 ectopic pregnancies were immunostained for CD71. NRBCs were morphologically evident in 23 cases: 12/23 abortive, 4/11 ectopic, and 7/10 partial molar pregnancies. CD71 immunolabeling detected NRBCs in all 23 previous cases and in 8 new cases: 2 partial moles and 6 spontaneous abortive pregnancies. No NRBCs were detected in complete moles by means of either morphology or immunohistochemistry (IHC). In 4 cases with extensive necrotic changes, CD71 marked NRBCs and a few ghost villi, which were not certainly identifiable with standard histological evaluation. Furthermore, there was an inversely proportional relationship between total percentage of CD71-positive NRBCs and gestational age (R=0.69; P<0.0001). We conclude that CD71 is a robust IHC marker for the detection of NRBCs and chorionic villi, especially in the presence of necrosis. The demonstration of NRBCs can be important in molar pathology, helping to exclude a complete mole. The application of CD71 could improve the diagnosis of this pathology in selected cases in which diffuse necrotic or hemorrhagic aspects may hinder the interpretation of the conventional approach with histology, IHC for p57, and ploidy analysis. Finally, the inverse correlation between the total percentage of CD71-positive NRBCs and gestational age suggests that this analysis may help in pregnancy dating.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 25906120     DOI: 10.1097/PAI.0000000000000175

Source DB:  PubMed          Journal:  Appl Immunohistochem Mol Morphol        ISSN: 1533-4058


  7 in total

1.  Fhit down-regulation is an early event in pancreatic carcinogenesis.

Authors:  Matteo Fassan; Borislav Rusev; Vincenzo Corbo; Pierluigi Gasparini; Claudio Luchini; Caterina Vicentini; Andrea Mafficini; Salvatore Paiella; Roberto Salvia; Ivana Cataldo; Aldo Scarpa; Kay Huebner
Journal:  Virchows Arch       Date:  2017-03-13       Impact factor: 4.064

2.  Juvenile polyposis diagnosed with an integrated histological, immunohistochemical and molecular approach identifying new SMAD4 pathogenic variants.

Authors:  Andrea Mafficini; Lodewijk A A Brosens; Maria L Piredda; Cristian Conti; Paola Mattiolo; Giulia Turri; Maria G Mastrosimini; Sara Cingarlini; Stefano F Crinò; Matteo Fassan; Paola Piccoli; Michele Simbolo; Alessia Nottegar; Rita T Lawlor; Alfredo Guglielmi; Aldo Scarpa; Corrado Pedrazzani; Claudio Luchini
Journal:  Fam Cancer       Date:  2022-01-25       Impact factor: 2.375

3.  A rare case of three different tumors in the same pancreatic specimen: a case report and brief review of the literature.

Authors:  Giulia De Marchi; Salvatore Paiella; Claudio Luchini; Antonio Amodio; Borislav Rusev; Claudio Bassi; Riccardo Manfredi; Luca Frulloni
Journal:  J Gastrointest Oncol       Date:  2016-06

4.  RASSF1 tumor suppressor gene in pancreatic ductal adenocarcinoma: correlation of expression, chromosomal status and epigenetic changes.

Authors:  Eliana Amato; Stefano Barbi; Matteo Fassan; Claudio Luchini; Caterina Vicentini; Matteo Brunelli; Giuseppe Malleo; Aldo Scarpa; Giorgio Malpeli
Journal:  BMC Cancer       Date:  2016-01-12       Impact factor: 4.430

5.  Solid Pseudopapillary Neoplasm of the Pancreas and Abdominal Desmoid Tumor in a Patient Carrying Two Different BRCA2 Germline Mutations: New Horizons from Tumor Molecular Profiling.

Authors:  Andrea Mafficini; Rita T Lawlor; Claudio Ghimenton; Davide Antonello; Cinzia Cantù; Gaetano Paolino; Alessia Nottegar; Maria L Piredda; Roberto Salvia; Michele Milella; Angelo P Dei Tos; Matteo Fassan; Aldo Scarpa; Claudio Luchini
Journal:  Genes (Basel)       Date:  2021-03-26       Impact factor: 4.096

6.  "Pure" hepatoid tumors of the pancreas harboring CTNNB1 somatic mutations: a new entity among solid pseudopapillary neoplasms.

Authors:  Paola Mattiolo; Andrea Mafficini; Rita T Lawlor; Giovanni Marchegiani; Giuseppe Malleo; Antonio Pea; Roberto Salvia; Paola Piccoli; Concetta Sciammarella; Nicola Santonicco; Alice Parisi; Nicola Silvestris; Michele Milella; Volkan Adsay; Aldo Scarpa; Claudio Luchini
Journal:  Virchows Arch       Date:  2022-03-31       Impact factor: 4.535

7.  CD117 Is a Specific Marker of Intraductal Papillary Mucinous Neoplasms (IPMN) of the Pancreas, Oncocytic Subtype.

Authors:  Paola Mattiolo; Seung-Mo Hong; Gaetano Paolino; Borislav C Rusev; Giovanni Marchegiani; Roberto Salvia; Stefano Andrianello; Paola Capelli; Paola Piccoli; Claudia Parolini; Aldo Scarpa; Rita T Lawlor; Claudio Luchini
Journal:  Int J Mol Sci       Date:  2020-08-12       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.